| Literature DB >> 31437226 |
Rosemeire Cobo Zanella1, Maria Cristina de Cunto Brandileone1, Samanta Cristine Grassi Almeida1, Ana Paula Silva de Lemos1, Claudio Tavares Sacchi2, Claudia R Gonçalves2, Maria Gisele Gonçalves3, Lucila Okuyama Fukasawa3, Marcos Daniel Saraiva4, Luís Fernando Rangel4, Julia Lusis Lassance Cunha4, Thereza Cristina Ariza Rotta4, Christian Douradinho4, Wilson Jacob-Filho4, Ruth Minamisava5, Ana Lúcia Andrade6.
Abstract
We aimed to investigate the nasopharyngeal colonization (NPC) by Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in the elderly population and to assess the demographic factors associated with NPC. This was an observational cohort study in which outpatients aged ≥60 years were enrolled from April to August 2017, with a follow-up visit from September through December 2017. Nasopharyngeal (NP) swabs were collected, bacteria were detected and isolated, and isolates were subjected to phenotypic and molecular characterization using standard microbiological techniques. At enrolment, the rates of S. aureus, methicillin-resistant S. aureus (MRSA), H. influenzae, and S. pneumoniae among 776 elderly outpatients were 15.9%, 2.3%, 2.5%, and 2.2%, respectively. Toxin production was detected in 21.1% of methicillin-susceptible S. aureus, and three SCCmec types were identified: II/IIb, IVa, and VI. At the follow-up visit, all carriage rates were similar (p > 0.05) to the rates at enrolment. Most of S. pneumoniae serotypes were not included in pneumococcal conjugate vaccines (PCVs), except for 7F, 3, and 19A. All strains of H. influenzae were non-typeable. Previous use of antibiotics and 23-valent pneumococcal polysaccharide vaccination (p < 0.05) were risk factors for S. aureus and MRSA carriage; S. aureus colonization was also associated with chronic kidney disease (p = 0.021). S. pneumoniae carriage was associated with male gender (p = 0.032) and an absence of diabetes (p = 0.034), while not receiving an influenza vaccine (p = 0.049) and chronic obstructive pulmonary disease (p = 0.031) were risk factors for H. influenzae colonization. The frailty of study participants was not associated with colonization status. We found a higher S. aureus carriage rate compared with the S. pneumoniae- and H. influenzae-carriage rates in a well-attended population in a geriatric outpatient clinic. This is one of the few studies conducted in Brazil that can support future colonization studies among elderly individuals.Entities:
Mesh:
Year: 2019 PMID: 31437226 PMCID: PMC6705818 DOI: 10.1371/journal.pone.0221525
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic and clinical characteristics of elderly participants in both visit 1 and the follow-up visit (visit 2).
| Characteristics | Visit 1 | Visit 2 | ||
|---|---|---|---|---|
| N | % | n | % | |
| Female | 554 | 71.39 | 429 | 73.46 |
| Living in a long-term institution | 13 | 1.68 | 10 | 1.71 |
| Living with a child | 134 | 17.27 | 108 | 18.49 |
| no information | 1 | 0.13 | 1 | 0.17 |
| Influenza vaccine | 690 | 88.92 | 538 | 92.12 |
| PPSV23 vaccine | 203 | 26.16 | 180 | 30.82 |
| Caucasian | 442 | 56.96 | 330 | 56.51 |
| Marriage | 264 | 34.02 | 200 | 34.25 |
| School education (≤4 years) | 563 | 72.55 | 425 | 72.77 |
| Hospitalization in the last 6 months | 117 | 15.08 | 76 | 13.01 |
| Antibiotic use in the last 12 months | 338 | 43.56 | 252 | 43.15 |
| Diabetes | ||||
| Yes | 281 | 36.21 | 208 | 35.62 |
| No | 495 | 63.79 | 376 | 64.38 |
| COPD | ||||
| Yes | 51 | 6.57 | 35 | 5.99 |
| No | 725 | 93.43 | 549 | 94.01 |
| Asthma | ||||
| Yes | 35 | 4.51 | 29 | 4.97 |
| No | 741 | 95.49 | 555 | 95.03 |
| Chronic Kidney Disease | ||||
| Yes | 172 | 22.16 | 127 | 21.75 |
| No | 604 | 77.84 | 457 | 78.25 |
| Smoking | ||||
| Yes | 100 | 12.89 | 75 | 12.84 |
| No | 676 | 87.11 | 509 | 87.16 |
| SOF Frailty Scale | ||||
| Robust | 282 | 36.34 | 210 | 35.96 |
| Pre-frail | 275 | 35.44 | 209 | 35.79 |
| Frail | 219 | 28.22 | 165 | 28.25 |
a The median age was 81.5 years (range: 60–102 years) for visit 1 and 81.9 years (range: 60–103 years) for the follow-up visit.
b PPSV23 vaccine, 23-valent pneumococcal polysaccharide vaccine
c COPD, chronic obstructive pulmonary disease
d SOF, Study of Osteoporotic Fractures
Nasopharyngeal carriage prevalence of Streptococcus pneumoniae, Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), and Haemophilus influenzae in elderly individuals > 60 years of age considering the subset of participants seen in both visit 1 and the follow-up visit (visit 2; n = 584).
| Carriage | n = 776 | n = 584 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Visit 1 | Visit 1 | Visit 2 | |||||||
| n | % | 95% CI | n | % | 95% CI | n | % | 95% IC | |
| 123 | 15.9 | 13.5–18.6 | 91 | 15.6 | 12.9–18.8 | 105 | 18.0 | 15.1–21.3 | |
| MRSA | 18 | 2.3 | 1.5–3.6 | 12 | 2.1 | 1.2–3.6 | 18 | 3.1 | 2.0–4.8 |
| 17 | 2.2 | 1.4–3.5 | 9 | 1.5 | 0.8–2.9 | 15 | 2.6 | 1.6–4.2 | |
| 19 | 2.5 | 1.6–3.8 | 14 | 2.4 | 1.4–4.0 | 10 | 1.7 | 0.9–3.1 | |
a Subset composed of the same individuals for visit 1 and follow-up visit (visit 2)
b,c,d All non-typeable isolates
Demographic characteristics, medical conditions, and risk factors for carriage of Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pneumoniae, and Haemophilus influenzae in visit 1 among elderly participants (N = 776).
| Variable | MRSA | Total | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| positive | % | p-value | positive | % | p-value | positive | % | p-value | Positive | % | p-value | |||
| Gender | ||||||||||||||
| Female (n = 554) | 80 | 14.4 | 0.089 | 11 | 2.0 | 0.329 | 8 | 1.4 | 0.032 | 12 | 2.2 | 0.421 | 554 | |
| Male (n = 222) | 43 | 19.4 | 7 | 3.2 | 9 | 4.1 | 7 | 3.2 | 222 | |||||
| Living in a long-term institution | ||||||||||||||
| No (n = 763) | 120 | 15.7 | 0.444 | 17 | 2.2 | 0.265 | 16 | 2.1 | 0.252 | 19 | 2.5 | - | 763 | |
| Yes (n = 13) | 3 | 23.1 | 1 | 7.7 | 1 | 7.7 | 0 | 0.0 | 13 | |||||
| Living with child | ||||||||||||||
| No (n = 642) | 101 | 15.8 | 0.849 | 18 | 2.8 | - | 15 | 2.3 | 0.751 | 15 | 2.3 | 0.757 | 641 | |
| Yes (n = 134) | 22 | 16.4 | 0 | 0.0 | 2 | 1.5 | 4 | 3.0 | 134 | |||||
| Influenza vaccine | ||||||||||||||
| No (n = 86) | 11 | 12.8 | 0.410 | 0 | 0.0 | - | 3 | 3.5 | 0.422 | 5 | 5.8 | 0.049 | 86 | |
| Yes (n = 690) | 112 | 16.2 | 18 | 2.6 | 14 | 2.0 | 14 | 2.0 | 690 | |||||
| PPSV23 vaccine | ||||||||||||||
| No (n = 573) | 82 | 14.3 | 0.048 | 8 | 1.4 | 0.011 | 13 | 2.3 | 1.000 | 13 | 2.3 | 0.600 | 573 | |
| Yes (n = 203) | 41 | 20.2 | 10 | 4.9 | 4 | 2.0 | 6 | 3.0 | 203 | |||||
| Marriage | ||||||||||||||
| No (n = 512) | 79 | 15.4 | 0.655 | 13 | 2.5 | 0.572 | 9 | 1.8 | 0.251 | 12 | 2.3 | 0.793 | 512 | |
| Yes (n = 264) | 44 | 16.7 | 5 | 1.9 | 8 | 3.0 | 7 | 2.7 | 264 | |||||
| School education | ||||||||||||||
| ≤4 years (n = 563) | 89 | 15.8 | 0.958 | 12 | 2.1 | 0.596 | 13 | 2.3 | 1.000 | 16 | 2.8 | 0.249 | 563 | |
| ≥5 years (n = 213) | 34 | 16.0 | 6 | 2.8 | 4 | 1.9 | 3 | 1.4 | 213 | |||||
| Hospitalization in previous 6 months | ||||||||||||||
| No (n = 659) | 104 | 15.8 | 0.901 | 14 | 2.1 | 0.333 | 15 | 2.3 | 1.000 | 16 | 2.4 | 1.000 | 659 | |
| Yes (n = 117) | 19 | 16.2 | 4 | 3.4 | 2 | 1.7 | 3 | 2.6 | 117 | |||||
| Antibiotic use in the last 12 months | ||||||||||||||
| No (n = 438) | 59 | 13.5 | .039 | 5 | 1.1 | 0.013 | 10 | 2.3 | 0.841 | 12 | 2.7 | 0.550 | 438 | |
| Yes (n = 338) | 64 | 18.9 | 13 | 3.8 | 7 | 2.1 | 7 | 2.1 | 338 | |||||
| Diabetes | ||||||||||||||
| No (n = 495) | 81 | 16.4 | 0.603 | 12 | 2.4 | 0.797 | 15 | 3.0 | 0.034 | 13 | 2.6 | 0.671 | 495 | |
| Yes (n = 281) | 42 | 14.9 | 6 | 2.1 | 2 | 0.7 | 6 | 2.1 | 281 | |||||
| COPD | ||||||||||||||
| No (n = 725) | 113 | 15.6 | 0.447 | 17 | 2.3 | 1.000 | 14 | 1.9 | 0.095 | 15 | 2.1 | 0.031 | 725 | |
| Yes (n = 51) | 10 | 19.6 | 1 | 2.0 | 3 | 5.9 | 4 | 7.8 | 51 | |||||
| Asthma | ||||||||||||||
| No (n = 741) | 116 | 15.7 | 0.492 | 18 | 2.4 | - | 15 | 2.0 | 0.176 | 19 | 2.6 | - | 741 | |
| Yes (n = 35) | 7 | 20.0 | 0 | 0.0 | 2 | 5.7 | 0 | 0.0 | 35 | |||||
| Chronic kidney disease | ||||||||||||||
| No (n = 604) | 86 | 14.2 | 0.021 | 11 | 1.8 | 0.091 | 13 | 2.2 | 1.000 | 17 | 2.8 | 0.274 | 604 | |
| Yes (n = 172) | 37 | 21.5 | 7 | 4.1 | 4 | 2.3 | 2 | 1.2 | 172 | |||||
| Smoking | ||||||||||||||
| Yes (n = 676) | 101 | 14.9 | 0.071 | 14 | 2.1 | 0.273 | 12 | 1.8 | 0.056 | 16 | 2.4 | 0.725 | 676 | |
| No (n = 100) | 22 | 22.0 | 4 | 4.0 | 5 | 5.0 | 3 | 3.0 | 100 | |||||
| SOF Frailty Scale | ||||||||||||||
| Robust (n = 282) | 42 | 14.9 | 0.837 | 4 | 1.4 | 0.422 | 5 | 1.8 | 0.816 | 6 | 2.1 | 0.712 | 282 | |
| Pre-frail (n = 275) | 46 | 16.7 | 8 | 2.9 | 7 | 2.5 | 6 | 2.2 | 275 | |||||
| Frail (n = 219) | 35 | 15.9 | 6 | 2.7 | 5 | 2.3 | 7 | 3.2 | 219 | |||||
a Visit 1 mean age: 81.5 years (range: 60–102 years old)
b PPSV23 vaccine, 23-valent pneumococcal polysaccharide vaccine
cCOPD, chronic obstructive pulmonary disease
dSOF Frailty Scale, Study of Osteoporotic Fractures